GlassScriptPhysician profile
Ralph V Clayman
NPI 1336243922
$523,236.54
in general payments reported to CMS, 2019-2025
14 companies · $335 in 2025
The $335 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293K · 2020: $63K · 2021: $64K · 2022: $66K · 2023: $37K · 2024: $566 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $33K · Consulting Fee: $3,590 · Food and Beverage: $1,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $32,842.35 |
| Consulting Fee | $3,590.00 |
| Food and Beverage | $1,074.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $271,488.77 | 2019-2023 | S~Curve |
| Ethicon INC. | $243,787.08 | 2019-2022 | |
| Sanofi US Services INC. | $3,590.00 | 2023 | |
| Urogen Pharma, INC. | $2,160.00 | 2021-2022 | |
| Cook Medical LLC | $969.64 | 2019-2025 | Fiber Dust, Litho 150 |
| Edap Technomed INC | $345.00 | 2024 | |
| Calyxo, INC. | $271.55 | 2024-2025 | Cvac Aspiration System |
| Dornier Medtech America, INC | $163.39 | 2019 | |
| Medical Device Business Services, INC. | $149.79 | 2024 | |
| Conmed Corporation | $147.48 | 2022 | |
| Karl Storz Endoscopy-America | $104.05 | 2019 | |
| Stryker Corporation | $34.88 | 2023 | Spy-Phi System |
| Novo Nordisk INC | $24.91 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$23,546,400.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Clayman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.